| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | STAT family protein binding | 1.92e-05 | 13 | 83 | 3 | GO:0097677 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.68e-04 | 303 | 83 | 7 | GO:0003713 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | BMI1 CEBPA MEGF8 KIAA1217 ROR2 GATA3 TBXT PAX7 ZMIZ1 SSBP3 PCDH8 EP300 CNOT3 FOXF1 AXIN1 | 2.10e-06 | 906 | 81 | 15 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | BMI1 CEBPA MEGF8 KIAA1217 ROR2 GATA3 TBXT PAX7 ZMIZ1 SSBP3 PCDH8 EP300 CNOT3 FOXF1 AXIN1 | 2.86e-06 | 929 | 81 | 15 | GO:0009792 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 4.92e-06 | 242 | 81 | 8 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 4.92e-06 | 242 | 81 | 8 | GO:1903708 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | ZNF142 CEBPA SPI1 GATA3 SMARCA2 AKNA AUTS2 TBXT STING1 PAX7 ZMIZ1 CAMTA1 SSBP3 IFI16 MAML3 EP300 BSX FOXF1 | 5.71e-06 | 1390 | 81 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin remodeling | BMI1 SPHK2 SPI1 BICRA GATA3 SMARCA2 SMARCC2 RERE PAX7 IFI16 SPTY2D1 EP300 AXIN1 | 5.90e-06 | 741 | 81 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | segmentation | 8.96e-06 | 123 | 81 | 6 | GO:0035282 | |
| GeneOntologyBiologicalProcess | somitogenesis | 1.22e-05 | 76 | 81 | 5 | GO:0001756 | |
| GeneOntologyBiologicalProcess | macrophage differentiation | 1.31e-05 | 77 | 81 | 5 | GO:0030225 | |
| GeneOntologyBiologicalProcess | regionalization | 1.75e-05 | 478 | 81 | 10 | GO:0003002 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 2.57e-05 | 148 | 81 | 6 | GO:0048706 | |
| GeneOntologyBiologicalProcess | skeletal system development | BMI1 BNC2 MEGF8 KIAA1217 ROR2 GATA3 TBXT PAX7 SIK3 EP300 AXIN1 | 2.77e-05 | 615 | 81 | 11 | GO:0001501 |
| GeneOntologyBiologicalProcess | somite development | 3.44e-05 | 94 | 81 | 5 | GO:0061053 | |
| GeneOntologyBiologicalProcess | pattern specification process | 3.96e-05 | 526 | 81 | 10 | GO:0007389 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | BMI1 CEBPA CSF1 SPI1 ROR2 GATA3 SMARCA2 SMARCC2 ZMIZ1 IFI16 EP300 | 3.98e-05 | 640 | 81 | 11 | GO:1903131 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 4.17e-05 | 423 | 81 | 9 | GO:0002696 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 4.27e-05 | 162 | 81 | 6 | GO:0045621 | |
| GeneOntologyBiologicalProcess | chromatin organization | BMI1 SPHK2 SPI1 BICRA GATA3 SMARCA2 SMARCC2 RERE PAX7 IFI16 SPTY2D1 EP300 AXIN1 | 4.36e-05 | 896 | 81 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | developmental growth | BNC2 CSF1 MEGF8 ATXN2 KIF26B GATA3 AUTS2 TMEM108 PAX7 ZMIZ1 SIK3 PICALM EP300 | 5.17e-05 | 911 | 81 | 13 | GO:0048589 |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 5.31e-05 | 247 | 81 | 7 | GO:0009952 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | BMI1 RHOXF2B CEBPA SPI1 RHOXF2 GATA3 SMARCA2 SMARCC2 TBXT MAGEC1 IFI16 ATXN1L EP300 FOXF1 | 5.56e-05 | 1053 | 81 | 14 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | CBLL1 BMI1 CSF1 SPI1 KIF26B GATA3 SMARCA2 AKNA SMARCC2 ZMIZ1 PCDH8 EP300 FOXF1 | 6.18e-05 | 927 | 81 | 13 | GO:0030155 |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 6.61e-05 | 449 | 81 | 9 | GO:0050867 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 7.09e-05 | 351 | 81 | 8 | GO:0048562 | |
| GeneOntologyBiologicalProcess | growth | BNC2 SPHK2 CSF1 MEGF8 ATXN2 KIF26B GATA3 SMARCA2 AUTS2 TMEM108 PAX7 ZMIZ1 SIK3 PICALM EP300 | 8.14e-05 | 1235 | 81 | 15 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | BMI1 SPI1 KIF26B GATA3 SMARCA2 AKNA SMARCC2 ZMIZ1 PCDH8 EP300 | 8.94e-05 | 580 | 81 | 10 | GO:0022407 |
| GeneOntologyBiologicalProcess | pro-T cell differentiation | 9.09e-05 | 4 | 81 | 2 | GO:0002572 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | BMI1 RHOXF2B CEBPA SPI1 RHOXF2 GATA3 SMARCA2 SMARCC2 TBXT RERE MAGEC1 IFI16 ATXN1L EP300 FOXF1 AXIN1 | 9.25e-05 | 1399 | 81 | 16 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | BMI1 RHOXF2B CEBPA SPI1 RHOXF2 GATA3 SMARCA2 SMARCC2 TBXT RERE MAGEC1 IFI16 ATXN1L EP300 FOXF1 AXIN1 | 1.04e-04 | 1413 | 81 | 16 | GO:1902679 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | BMI1 CSF1 MEGF8 KIF26B SOBP ROR2 GATA3 TBXT PAX7 ZMIZ1 SIK3 EP300 BSX FOXF1 AXIN1 | 1.10e-04 | 1269 | 81 | 15 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryo development | BMI1 CEBPA MEGF8 SOBP KIAA1217 ROR2 GATA3 TBXT PAX7 ZMIZ1 SSBP3 PCDH8 EP300 CNOT3 FOXF1 AXIN1 | 1.26e-04 | 1437 | 81 | 16 | GO:0009790 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BMI1 SPHK2 SPI1 BICRA GATA3 SMARCA2 SMARCC2 RERE PAX7 IFI16 SPTY2D1 EP300 AXIN1 | 1.31e-04 | 999 | 81 | 13 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | CSF1 SPI1 MEGF8 ROR2 GATA3 SMARCA2 SMARCC2 ZMIZ1 PICALM EP300 | 1.43e-04 | 614 | 81 | 10 | GO:0010720 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 1.74e-04 | 299 | 81 | 7 | GO:0060560 | |
| GeneOntologyBiologicalProcess | head development | BMI1 SPHK2 AFF2 ATXN2 AKNA TMEM108 RERE ZMIZ1 SSBP3 ATXN1L EP300 AXIN1 | 2.37e-04 | 919 | 81 | 12 | GO:0060322 |
| GeneOntologyBiologicalProcess | leukocyte differentiation | BMI1 CEBPA CSF1 SPI1 ROR2 GATA3 SMARCA2 SMARCC2 ZMIZ1 IFI16 EP300 | 2.52e-04 | 789 | 81 | 11 | GO:0002521 |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 2.59e-04 | 144 | 81 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 2.64e-04 | 540 | 81 | 9 | GO:1903706 | |
| GeneOntologyBiologicalProcess | hemopoiesis | BMI1 CEBPA CSF1 SPI1 ROR2 GATA3 SMARCA2 SMARCC2 ZMIZ1 SSBP3 IFI16 ATXN1L PICALM EP300 | 2.68e-04 | 1223 | 81 | 14 | GO:0030097 |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 2.80e-04 | 429 | 81 | 8 | GO:1902105 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 2.92e-04 | 33 | 81 | 3 | GO:0000289 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 3.18e-04 | 330 | 81 | 7 | GO:0040029 | |
| GeneOntologyBiologicalProcess | tube development | BMI1 FNDC3B CEBPA CSF1 SPI1 MEGF8 KIF26B GATA3 TBXT PAX7 ZMIZ1 SSBP3 ATXN1L EP300 FOXF1 | 3.27e-04 | 1402 | 81 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.50e-04 | 561 | 81 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | connective tissue development | 4.01e-04 | 343 | 81 | 7 | GO:0061448 | |
| GeneOntologyBiologicalProcess | delamination | 4.20e-04 | 8 | 81 | 2 | GO:0060232 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 4.40e-04 | 579 | 81 | 9 | GO:0045785 | |
| GeneOntologyBiologicalProcess | mammary gland development | 4.45e-04 | 162 | 81 | 5 | GO:0030879 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | FNDC3B CEBPA CSF1 SPI1 MEGF8 ROR2 GATA3 SMARCA2 SMARCC2 ZMIZ1 IFI16 PICALM EP300 | 4.76e-04 | 1141 | 81 | 13 | GO:0045597 |
| GeneOntologyBiologicalProcess | inner ear development | 4.83e-04 | 253 | 81 | 6 | GO:0048839 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 6.29e-04 | 266 | 81 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | BMI1 FNDC3B SPHK2 CSF1 BICRA SMARCA2 TBXT IRS1 PAX7 ZMIZ1 SSBP3 ATXN1L FOXF1 | 7.07e-04 | 1190 | 81 | 13 | GO:0008284 |
| GeneOntologyBiologicalProcess | neural tube patterning | 7.35e-04 | 45 | 81 | 3 | GO:0021532 | |
| GeneOntologyBiologicalProcess | central nervous system development | BMI1 SPHK2 AFF2 ATXN2 ROR2 TLX3 AKNA TMEM108 RERE PAX7 ZMIZ1 SSBP3 ATXN1L | 7.47e-04 | 1197 | 81 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | T cell differentiation | 7.59e-04 | 382 | 81 | 7 | GO:0030217 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 7.77e-04 | 277 | 81 | 6 | GO:0048705 | |
| GeneOntologyBiologicalProcess | dendrite extension | 7.84e-04 | 46 | 81 | 3 | GO:0097484 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 7.94e-04 | 385 | 81 | 7 | GO:0051251 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 8.44e-04 | 389 | 81 | 7 | GO:0022409 | |
| GeneOntologyBiologicalProcess | ear development | 9.00e-04 | 285 | 81 | 6 | GO:0043583 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CBLL1 BMI1 SPI1 KIF26B GATA3 SMARCA2 AKNA SMARCC2 ZMIZ1 PCDH8 EP300 FOXF1 | 9.75e-04 | 1077 | 81 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 9.85e-04 | 290 | 81 | 6 | GO:0050870 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | BMI1 SPHK2 CEBPA CSF1 SPI1 ROR2 GATA3 SMARCA2 SMARCC2 STING1 ZMIZ1 IFI16 EP300 | 1.05e-03 | 1242 | 81 | 13 | GO:0002684 |
| GeneOntologyBiologicalProcess | defense response to tumor cell | 1.16e-03 | 13 | 81 | 2 | GO:0002357 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte mediated immunity | 1.16e-03 | 13 | 81 | 2 | GO:0002887 | |
| GeneOntologyCellularComponent | chromatin | BMI1 BNC2 RHOXF2B SPHK2 CEBPA SPI1 BICRA RHOXF2 TLX3 GATA3 SMARCA2 SMARCC2 TBXT PAX7 ZMIZ1 ESCO1 EP300 BSX FOXF1 | 3.36e-06 | 1480 | 82 | 19 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.19e-04 | 30 | 82 | 3 | GO:0016514 | |
| MousePheno | neonatal lethality | FNDC3B BNC2 NIPAL4 CEBPA SPI1 KIF26B ROR2 TLX3 SCNN1A AUTS2 TNRC6B SMARCC2 TBXT SIK3 ATXN1L FOXF1 | 8.04e-07 | 799 | 67 | 16 | MP:0002058 |
| MousePheno | perinatal lethality | FNDC3B BNC2 NIPAL4 CEBPA SPI1 KIF26B ROR2 TLX3 GATA3 SCNN1A AUTS2 TNRC6B SMARCC2 TBXT RERE SIK3 ATXN1L EP300 FOXF1 | 8.60e-07 | 1130 | 67 | 19 | MP:0002081 |
| MousePheno | short tail | 4.38e-06 | 90 | 67 | 6 | MP:0000592 | |
| MousePheno | abnormal tail length | 1.13e-05 | 106 | 67 | 6 | MP:0011999 | |
| MousePheno | abnormal cartilage morphology | 3.01e-05 | 336 | 67 | 9 | MP:0000163 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | BMI1 CEBPA CSF1 SPI1 AKNA TNRC6B SMARCC2 TBXT RERE PAX7 SIK3 SSBP3 ATXN1L PICALM EP300 FOXF1 | 6.09e-05 | 1124 | 67 | 16 | MP:0011112 |
| MousePheno | failure of myelopoiesis | 6.77e-05 | 3 | 67 | 2 | MP:0001603 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | FNDC3B BNC2 NIPAL4 CEBPA SPI1 MEGF8 BICRA ROR2 TLX3 SCNN1A AUTS2 SMARCC2 RERE CAMTA1 PICALM EP300 FOXF1 | 7.29e-05 | 1269 | 67 | 17 | MP:0011111 |
| MousePheno | abnormal bone marrow cell number | 9.30e-05 | 154 | 67 | 6 | MP:0000172 | |
| MousePheno | decreased birth body size | 1.18e-04 | 232 | 67 | 7 | MP:0009703 | |
| MousePheno | abnormal tail morphology | 1.22e-04 | 403 | 67 | 9 | MP:0002111 | |
| MousePheno | perinatal lethality, complete penetrance | FNDC3B BNC2 NIPAL4 CEBPA SPI1 ROR2 TLX3 SCNN1A AUTS2 RERE EP300 FOXF1 | 1.26e-04 | 712 | 67 | 12 | MP:0011089 |
| MousePheno | abnormal birth body size | 1.35e-04 | 237 | 67 | 7 | MP:0009701 | |
| MousePheno | postnatal lethality | BMI1 CEBPA CSF1 SPI1 AKNA SMARCC2 TBXT IRS1 RERE PAX7 CAMTA1 ATXN1L PICALM EP300 FOXF1 | 1.49e-04 | 1084 | 67 | 15 | MP:0002082 |
| MousePheno | kinked neural tube | 1.57e-04 | 57 | 67 | 4 | MP:0003400 | |
| MousePheno | abnormal cartilage development | 1.71e-04 | 172 | 67 | 6 | MP:0000164 | |
| MousePheno | abnormal spleen red pulp morphology | 1.80e-04 | 110 | 67 | 5 | MP:0002356 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 2.05e-04 | 113 | 67 | 5 | MP:0000165 | |
| MousePheno | neonatal lethality, complete penetrance | 2.12e-04 | 534 | 67 | 10 | MP:0011087 | |
| MousePheno | abnormal posterior primitive streak morphology | 2.24e-04 | 5 | 67 | 2 | MP:0012740 | |
| MousePheno | intrahepatic cholestasis | 2.24e-04 | 5 | 67 | 2 | MP:0005415 | |
| MousePheno | abnormal skeleton development | 2.66e-04 | 447 | 67 | 9 | MP:0002113 | |
| MousePheno | abnormal vertebral body morphology | 2.78e-04 | 66 | 67 | 4 | MP:0000141 | |
| MousePheno | postnatal lethality, incomplete penetrance | BMI1 CEBPA CSF1 SPI1 AKNA RERE PAX7 ATXN1L PICALM EP300 FOXF1 | 3.09e-04 | 669 | 67 | 11 | MP:0011086 |
| MousePheno | thin tail | 3.35e-04 | 6 | 67 | 2 | MP:0000589 | |
| MousePheno | abnormal axial skeleton morphology | BMI1 BNC2 CSF1 SPI1 MEGF8 TENT4A KIAA1217 ROR2 GATA3 TBXT ZC2HC1C PAX7 GGTLC2 SIK3 SSBP3 ATXN1L AXIN1 | 3.93e-04 | 1458 | 67 | 17 | MP:0002114 |
| MousePheno | respiratory distress | 4.27e-04 | 204 | 67 | 6 | MP:0001954 | |
| MousePheno | abnormal fibrous joint morphology | 4.66e-04 | 135 | 67 | 5 | MP:0030878 | |
| MousePheno | split notochord | 4.68e-04 | 7 | 67 | 2 | MP:0004713 | |
| MousePheno | small tail bud | 4.68e-04 | 7 | 67 | 2 | MP:0012062 | |
| MousePheno | abnormal tail bud morphology | 4.73e-04 | 32 | 67 | 3 | MP:0002861 | |
| MousePheno | rib fusion | 5.27e-04 | 78 | 67 | 4 | MP:0000154 | |
| MousePheno | neonatal lethality, incomplete penetrance | 5.43e-04 | 298 | 67 | 7 | MP:0011088 | |
| MousePheno | abnormal bone ossification | 5.75e-04 | 395 | 67 | 8 | MP:0008271 | |
| MousePheno | abnormal joint morphology | 5.94e-04 | 397 | 67 | 8 | MP:0002932 | |
| MousePheno | abnormal somite development | 6.67e-04 | 222 | 67 | 6 | MP:0001688 | |
| MousePheno | abnormal somite size | 6.71e-04 | 36 | 67 | 3 | MP:0005222 | |
| MousePheno | abnormal cartilaginous joint morphology | 7.29e-04 | 85 | 67 | 4 | MP:0030875 | |
| MousePheno | abnormal caudal vertebrae morphology | 7.96e-04 | 87 | 67 | 4 | MP:0002759 | |
| MousePheno | abnormal nucleus pulposus morphology | 7.97e-04 | 9 | 67 | 2 | MP:0006392 | |
| MousePheno | cholestasis | 7.97e-04 | 9 | 67 | 2 | MP:0000610 | |
| Domain | Homeodomain-like | 6.39e-04 | 332 | 82 | 7 | IPR009057 | |
| Domain | ZnF_GATA | 1.22e-03 | 12 | 82 | 2 | SM00401 | |
| Domain | DUF4599 | 1.22e-03 | 12 | 82 | 2 | PF15371 | |
| Domain | DUF4599 | 1.22e-03 | 12 | 82 | 2 | IPR027970 | |
| Domain | Homeobox_CS | 1.36e-03 | 186 | 82 | 5 | IPR017970 | |
| Domain | - | 1.53e-03 | 283 | 82 | 6 | 1.10.10.60 | |
| Domain | Znf_GATA | 1.93e-03 | 15 | 82 | 2 | IPR000679 | |
| Domain | GATA | 1.93e-03 | 15 | 82 | 2 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 2.20e-03 | 16 | 82 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 2.20e-03 | 16 | 82 | 2 | PS50114 | |
| Domain | Homeobox | 3.69e-03 | 234 | 82 | 5 | PF00046 | |
| Domain | HOMEOBOX_1 | 3.83e-03 | 236 | 82 | 5 | PS00027 | |
| Domain | HOX | 3.89e-03 | 237 | 82 | 5 | SM00389 | |
| Domain | HOMEOBOX_2 | 4.04e-03 | 239 | 82 | 5 | PS50071 | |
| Domain | Homeobox_dom | 4.04e-03 | 239 | 82 | 5 | IPR001356 | |
| Domain | Bromodomain_CS | 5.78e-03 | 26 | 82 | 2 | IPR018359 | |
| Domain | SANT_dom | 5.78e-03 | 26 | 82 | 2 | IPR017884 | |
| Domain | SANT | 6.68e-03 | 28 | 82 | 2 | PS51293 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 5.91e-08 | 237 | 46 | 9 | M27786 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.19e-07 | 37 | 46 | 5 | M27797 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.28e-06 | 34 | 46 | 4 | MM15531 | |
| Pathway | PID_CMYB_PATHWAY | 7.54e-06 | 84 | 46 | 5 | M195 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.56e-05 | 18 | 46 | 3 | MM14775 | |
| Pathway | WP_IL4_SIGNALING | 2.78e-05 | 54 | 46 | 4 | M39720 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.81e-05 | 65 | 46 | 4 | M39682 | |
| Pathway | REACTOME_GASTRULATION | 6.02e-05 | 129 | 46 | 5 | M46433 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.35e-04 | 153 | 46 | 5 | MM15522 | |
| Pathway | PID_REG_GR_PATHWAY | 1.44e-04 | 82 | 46 | 4 | M115 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.54e-04 | 95 | 46 | 4 | M48268 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.74e-04 | 39 | 46 | 3 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.41e-04 | 42 | 46 | 3 | M48237 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 4.61e-04 | 10 | 46 | 2 | MM15535 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 4.77e-04 | 47 | 46 | 3 | M7946 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | CEBPA SPI1 GATA3 SMARCA2 GPR143 TNRC6B SMARCC2 TBXT PAX7 MAML3 EP300 CNOT3 FOXF1 | 4.79e-04 | 1432 | 46 | 13 | M509 |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 6.73e-04 | 12 | 46 | 2 | M27159 | |
| Pathway | PID_AR_TF_PATHWAY | 6.80e-04 | 53 | 46 | 3 | M151 | |
| Pathway | WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS | 7.94e-04 | 13 | 46 | 2 | M39753 | |
| Pathway | WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS | 7.94e-04 | 13 | 46 | 2 | M39527 | |
| Pathway | REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN | 7.94e-04 | 13 | 46 | 2 | M27240 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 9.25e-04 | 14 | 46 | 2 | M27808 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 9.30e-04 | 59 | 46 | 3 | MM15838 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.02e-03 | 137 | 46 | 4 | M48232 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.03e-03 | 61 | 46 | 3 | M39540 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.06e-03 | 15 | 46 | 2 | MM1439 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27 | 1.06e-03 | 15 | 46 | 2 | M47973 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 1.13e-03 | 63 | 46 | 3 | M254 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 1.18e-03 | 64 | 46 | 3 | M27046 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.21e-03 | 16 | 46 | 2 | M27121 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.21e-03 | 16 | 46 | 2 | M8516 | |
| Pathway | REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES | 1.21e-03 | 16 | 46 | 2 | M27045 | |
| Pathway | PID_RB_1PATHWAY | 1.23e-03 | 65 | 46 | 3 | M279 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | BMI1 BNIP3L SPI1 GATA3 SMARCA2 AUTS2 TNRC6B SMARCC2 MAML3 EP300 CNOT3 AXIN1 | 1.28e-03 | 1387 | 46 | 12 | M734 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.39e-03 | 149 | 46 | 4 | M27888 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 1.47e-03 | 69 | 46 | 3 | M46439 | |
| Pathway | WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1 | 1.54e-03 | 18 | 46 | 2 | M48069 | |
| Pathway | PID_E2F_PATHWAY | 1.72e-03 | 73 | 46 | 3 | M40 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.79e-03 | 74 | 46 | 3 | M616 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.91e-03 | 20 | 46 | 2 | M27881 | |
| Pathway | WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS | 2.31e-03 | 22 | 46 | 2 | M39414 | |
| Pubmed | SOBP BICRA AUTS2 TNRC6B DTX2 ZMIZ1 SSBP3 ATXN1L SPTY2D1 EP300 | 3.49e-12 | 152 | 83 | 10 | 38360978 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SPATA6 ATXN2 SOBP BICRA KIAA1217 ROR2 SCNN1A SMARCA2 AUTS2 TNRC6B RIPOR1 RERE ZMIZ1 CAMTA1 SSBP3 MAML3 ESCO1 EP300 WNK2 | 1.67e-09 | 1489 | 83 | 19 | 28611215 |
| Pubmed | RNF214 ATXN2 SOBP BICRA TLX3 GATA3 SMARCA2 AUTS2 TNRC6B SMARCC2 TBXT RERE PAX7 ZMIZ1 SSBP3 ATXN1L EP300 CNOT3 | 5.91e-09 | 1429 | 83 | 18 | 35140242 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | BMI1 BNIP3L SPATA31E1 AFF2 ATXN2 BICRA PAX7 CAMTA1 PICALM WNK2 | 8.19e-08 | 430 | 83 | 10 | 35044719 |
| Pubmed | Developmental profiling of spiral ganglion neurons reveals insights into auditory circuit assembly. | 1.20e-07 | 49 | 83 | 5 | 21795542 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.67e-07 | 351 | 83 | 9 | 38297188 | |
| Pubmed | 2.32e-07 | 263 | 83 | 8 | 34702444 | ||
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 16601680 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 27764250 | ||
| Pubmed | 7.57e-07 | 131 | 83 | 6 | 34551306 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | BMI1 CEBPA SPI1 RHOXF2 TLX3 GATA3 RERE SSBP3 MAML3 EP300 CNOT3 PDLIM4 | 1.15e-06 | 877 | 83 | 12 | 20211142 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.50e-06 | 457 | 83 | 9 | 32344865 | |
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 21972064 | ||
| Pubmed | MEGF8 ATXN2 RHOXF2 TNRC6B SMARCC2 DTX2 RERE ATXN1L PCDH8 WNK2 | 1.92e-06 | 608 | 83 | 10 | 16713569 | |
| Pubmed | CBLL1 FKBP15 CTTNBP2 ATXN2 KIAA1217 TNRC6B SMARCC2 SEC31A SIK3 PCDH8 PICALM WNK2 | 3.02e-06 | 963 | 83 | 12 | 28671696 | |
| Pubmed | PU.1 regulates TCR expression by modulating GATA-3 activity. | 5.63e-06 | 2 | 83 | 2 | 19801513 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12087094 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18787208 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26121422 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17247577 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12027437 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29801457 | ||
| Pubmed | p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. | 5.63e-06 | 2 | 83 | 2 | 11340085 | |
| Pubmed | C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. | 5.63e-06 | 2 | 83 | 2 | 17671233 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29847803 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18308386 | ||
| Pubmed | Identification of a tandem duplicated array in the Rhox alpha locus on mouse chromosome X. | 5.63e-06 | 2 | 83 | 2 | 16465597 | |
| Pubmed | Cloning and characterization of the 5'-flanking region of the Ehox gene. | 5.63e-06 | 2 | 83 | 2 | 16414020 | |
| Pubmed | Modulation of vitamin D signaling by the pioneer factor CEBPA. | 5.63e-06 | 2 | 83 | 2 | 30550771 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 14660596 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23864317 | ||
| Pubmed | Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. | 5.63e-06 | 2 | 83 | 2 | 16210620 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30387140 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20206554 | ||
| Pubmed | A gene regulatory network armature for T lymphocyte specification. | 5.63e-06 | 2 | 83 | 2 | 19104054 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32240121 | ||
| Pubmed | Pre-B cell to macrophage transdifferentiation without significant promoter DNA methylation changes. | 5.63e-06 | 2 | 83 | 2 | 22086955 | |
| Pubmed | Rhox homeobox gene cluster: recent duplication of three family members. | 5.63e-06 | 2 | 83 | 2 | 16496311 | |
| Pubmed | Recurrent intragenic exon rearrangements of SOBP and AUTS2 in non-Hodgkin B-cell lymphoma. | 5.63e-06 | 2 | 83 | 2 | 31686349 | |
| Pubmed | Aligned Expression of IFI16 and STING Genes in RRMS Patients' Blood. | 5.63e-06 | 2 | 83 | 2 | 31362682 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35878022 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 5031320 | ||
| Pubmed | 6.02e-06 | 407 | 83 | 8 | 12693553 | ||
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 7.18e-06 | 16 | 83 | 3 | 9710619 | |
| Pubmed | ZCCHC14 RHOXF2B CEBPA RHOXF2 GATA3 SMARCA2 TBXT PAX7 MAML3 PDLIM4 | 7.42e-06 | 709 | 83 | 10 | 22988430 | |
| Pubmed | BMI1 BNIP3L TENT4A SMARCA2 IRS1 GGTLC2 B3GNT3 SIK3 EP300 WNK2 | 9.56e-06 | 730 | 83 | 10 | 34857952 | |
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 1.04e-05 | 18 | 83 | 3 | 28068325 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.05e-05 | 908 | 83 | 11 | 19274049 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZCCHC14 SPHK2 MEGF8 BICRA AKNA RIPOR1 IRS1 DTX2 WRAP53 SIPA1L2 EP300 WNK2 | 1.21e-05 | 1105 | 83 | 12 | 35748872 |
| Pubmed | 1.24e-05 | 19 | 83 | 3 | 23563609 | ||
| Pubmed | 1.45e-05 | 20 | 83 | 3 | 16943278 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28378055 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 29453291 | ||
| Pubmed | Genetic interactions suggest that Danforth's short tail (Sd) is a gain-of-function mutation. | 1.69e-05 | 3 | 83 | 2 | 9706697 | |
| Pubmed | Inhibition of AIM2 inflammasome activation by a novel transcript isoform of IFI16. | 1.69e-05 | 3 | 83 | 2 | 30104205 | |
| Pubmed | PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells. | 1.69e-05 | 3 | 83 | 2 | 26361334 | |
| Pubmed | Regulation of Th2 cell development by Polycomb group gene bmi-1 through the stabilization of GATA3. | 1.69e-05 | 3 | 83 | 2 | 17114435 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18562707 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 32209471 | ||
| Pubmed | Stage-specific action of Runx1 and GATA3 controls silencing of PU.1 expression in mouse pro-T cells. | 1.69e-05 | 3 | 83 | 2 | 34180951 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 12091339 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 17107955 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26678520 | ||
| Pubmed | Viral hijacking of the TENT4-ZCCHC14 complex protects viral RNAs via mixed tailing. | 1.69e-05 | 3 | 83 | 2 | 32451488 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23252456 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 34216619 | ||
| Pubmed | The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis. | 1.69e-05 | 3 | 83 | 2 | 35867748 | |
| Pubmed | IL4 blockade of inducible regulatory T cell differentiation: the role of Th2 cells, Gata3 and PU.1. | 1.69e-05 | 3 | 83 | 2 | 19046990 | |
| Pubmed | IFI16 and cGAS cooperate in the activation of STING during DNA sensing in human keratinocytes. | 1.69e-05 | 3 | 83 | 2 | 28194029 | |
| Pubmed | Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression. | 1.69e-05 | 3 | 83 | 2 | 27488898 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18077458 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 21402921 | ||
| Pubmed | Derivation of mutant t-haplotypes of the mouse by presumed duplication or deletion. | 1.69e-05 | 3 | 83 | 2 | 924142 | |
| Pubmed | 1.94e-05 | 66 | 83 | 4 | 23275444 | ||
| Pubmed | 2.16e-05 | 486 | 83 | 8 | 20936779 | ||
| Pubmed | 2.56e-05 | 24 | 83 | 3 | 17182866 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 17562868 | ||
| Pubmed | PU.1 expression delineates heterogeneity in primary Th2 cells. | 3.37e-05 | 4 | 83 | 2 | 15963784 | |
| Pubmed | cGAS and Ifi204 cooperate to produce type I IFNs in response to Francisella infection. | 3.37e-05 | 4 | 83 | 2 | 25710914 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 11864910 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 10078198 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 28885975 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 15632071 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 16983342 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 24216764 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 16537903 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 16452305 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 15707895 | ||
| Pubmed | Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and Gata3. | 3.37e-05 | 4 | 83 | 2 | 23444353 | |
| Pubmed | Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis. | 3.37e-05 | 4 | 83 | 2 | 23708658 | |
| Pubmed | SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function. | 3.37e-05 | 4 | 83 | 2 | 33434504 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 28947539 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 24379003 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 17150957 | ||
| Pubmed | IFI207, a young and fast-evolving protein, controls retroviral replication via the STING pathway. | 3.37e-05 | 4 | 83 | 2 | 38860764 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 30061199 | ||
| Pubmed | 3.68e-05 | 27 | 83 | 3 | 29374058 | ||
| Pubmed | 3.76e-05 | 383 | 83 | 7 | 19453261 | ||
| Pubmed | 3.84e-05 | 157 | 83 | 5 | 30186101 | ||
| Pubmed | 4.11e-05 | 28 | 83 | 3 | 33953184 | ||
| Interaction | SS18L1 interactions | 6.20e-09 | 98 | 82 | 8 | int:SS18L1 | |
| Interaction | NFIC interactions | 1.36e-08 | 210 | 82 | 10 | int:NFIC | |
| Interaction | MAML1 interactions | 1.87e-08 | 73 | 82 | 7 | int:MAML1 | |
| Interaction | FOXC1 interactions | FKBP15 CEBPA SPI1 TLX3 GATA3 SMARCA2 SMARCC2 TBXT PAX7 EP300 | 2.96e-08 | 228 | 82 | 10 | int:FOXC1 |
| Interaction | TLE3 interactions | CBLL1 CEBPA TLX3 GATA3 AUTS2 SMARCC2 TBXT RERE PAX7 ZMIZ1 ATXN1L EP300 | 3.82e-08 | 376 | 82 | 12 | int:TLE3 |
| Interaction | EYA4 interactions | SOBP BICRA AUTS2 TNRC6B DTX2 ZMIZ1 SSBP3 ATXN1L SPTY2D1 EP300 | 5.40e-08 | 243 | 82 | 10 | int:EYA4 |
| Interaction | BCL9 interactions | 5.90e-08 | 86 | 82 | 7 | int:BCL9 | |
| Interaction | NFIA interactions | 7.20e-08 | 188 | 82 | 9 | int:NFIA | |
| Interaction | CRX interactions | BICRA RHOXF2 ROR2 TLX3 SMARCA2 RERE ZMIZ1 ATXN1L PICALM EP300 | 8.18e-08 | 254 | 82 | 10 | int:CRX |
| Interaction | NFIB interactions | 1.14e-07 | 142 | 82 | 8 | int:NFIB | |
| Interaction | GATA2 interactions | 1.17e-07 | 199 | 82 | 9 | int:GATA2 | |
| Interaction | DPF1 interactions | 1.18e-07 | 95 | 82 | 7 | int:DPF1 | |
| Interaction | ZNF609 interactions | 1.42e-07 | 146 | 82 | 8 | int:ZNF609 | |
| Interaction | NCOR1 interactions | CEBPA TLX3 GATA3 SMARCA2 SMARCC2 TBXT DTX2 SEC31A PAX7 ATXN1L EP300 | 2.49e-07 | 363 | 82 | 11 | int:NCOR1 |
| Interaction | SATB1 interactions | 4.64e-07 | 116 | 82 | 7 | int:SATB1 | |
| Interaction | ETS1 interactions | 6.19e-07 | 121 | 82 | 7 | int:ETS1 | |
| Interaction | ARID1B interactions | 6.19e-07 | 177 | 82 | 8 | int:ARID1B | |
| Interaction | SMARCD2 interactions | 7.97e-07 | 183 | 82 | 8 | int:SMARCD2 | |
| Interaction | NUP35 interactions | FNDC3B ATXN2 SMARCA2 AUTS2 TNRC6B DTX2 STING1 ZMIZ1 IFI16 MAML3 EP300 | 1.15e-06 | 424 | 82 | 11 | int:NUP35 |
| Interaction | IRF4 interactions | 1.28e-06 | 85 | 82 | 6 | int:IRF4 | |
| Interaction | PRRC2B interactions | 1.30e-06 | 265 | 82 | 9 | int:PRRC2B | |
| Interaction | SMARCA2 interactions | 1.40e-06 | 346 | 82 | 10 | int:SMARCA2 | |
| Interaction | PRR12 interactions | 1.57e-06 | 88 | 82 | 6 | int:PRR12 | |
| Interaction | SS18 interactions | 1.57e-06 | 88 | 82 | 6 | int:SS18 | |
| Interaction | HNRNPD interactions | BMI1 FNDC3B CEBPA SPATA31E1 ATXN2 SMARCC2 DTX2 SEC31A STING1 ZMIZ1 IFI16 PICALM EP300 | 1.70e-06 | 638 | 82 | 13 | int:HNRNPD |
| Interaction | ARID1A interactions | 1.82e-06 | 276 | 82 | 9 | int:ARID1A | |
| Interaction | PCGF1 interactions | 2.08e-06 | 208 | 82 | 8 | int:PCGF1 | |
| Interaction | ATXN1L interactions | 2.62e-06 | 150 | 82 | 7 | int:ATXN1L | |
| Interaction | FUBP3 interactions | 3.32e-06 | 297 | 82 | 9 | int:FUBP3 | |
| Interaction | ZNF503 interactions | 3.50e-06 | 57 | 82 | 5 | int:ZNF503 | |
| Interaction | NCOA3 interactions | 3.61e-06 | 224 | 82 | 8 | int:NCOA3 | |
| Interaction | FBRS interactions | 3.72e-06 | 102 | 82 | 6 | int:FBRS | |
| Interaction | RNF214 interactions | 4.16e-06 | 104 | 82 | 6 | int:RNF214 | |
| Interaction | KDM6A interactions | 4.37e-06 | 162 | 82 | 7 | int:KDM6A | |
| Interaction | TBR1 interactions | 6.73e-06 | 113 | 82 | 6 | int:TBR1 | |
| Interaction | LDB1 interactions | 7.45e-06 | 115 | 82 | 6 | int:LDB1 | |
| Interaction | BCL7C interactions | 7.45e-06 | 115 | 82 | 6 | int:BCL7C | |
| Interaction | TBXT interactions | 7.83e-06 | 116 | 82 | 6 | int:TBXT | |
| Interaction | KRTAP19-7 interactions | 8.23e-06 | 117 | 82 | 6 | int:KRTAP19-7 | |
| Interaction | SSBP3 interactions | 9.07e-06 | 119 | 82 | 6 | int:SSBP3 | |
| Interaction | LSM14A interactions | 1.08e-05 | 260 | 82 | 8 | int:LSM14A | |
| Interaction | HIVEP1 interactions | 1.08e-05 | 186 | 82 | 7 | int:HIVEP1 | |
| Interaction | BCL7A interactions | 1.10e-05 | 123 | 82 | 6 | int:BCL7A | |
| Interaction | NCOR2 interactions | 1.20e-05 | 264 | 82 | 8 | int:NCOR2 | |
| Interaction | DPF2 interactions | 1.22e-05 | 349 | 82 | 9 | int:DPF2 | |
| Interaction | SMARCD1 interactions | 1.22e-05 | 349 | 82 | 9 | int:SMARCD1 | |
| Interaction | TBL1XR1 interactions | 1.33e-05 | 192 | 82 | 7 | int:TBL1XR1 | |
| Interaction | SMARCC2 interactions | 1.33e-05 | 353 | 82 | 9 | int:SMARCC2 | |
| Interaction | ACTMAP interactions | 1.36e-05 | 75 | 82 | 5 | int:ACTMAP | |
| Interaction | KRTAP7-1 interactions | 1.69e-05 | 38 | 82 | 4 | int:KRTAP7-1 | |
| Interaction | SMARCA4 interactions | 1.78e-05 | 462 | 82 | 10 | int:SMARCA4 | |
| Interaction | DCAF7 interactions | 1.85e-05 | 368 | 82 | 9 | int:DCAF7 | |
| Interaction | TLX3 interactions | 2.43e-05 | 291 | 82 | 8 | int:TLX3 | |
| Interaction | SMARCC1 interactions | 2.59e-05 | 384 | 82 | 9 | int:SMARCC1 | |
| Interaction | BICRAL interactions | 2.78e-05 | 43 | 82 | 4 | int:BICRAL | |
| Interaction | DAZL interactions | 2.79e-05 | 145 | 82 | 6 | int:DAZL | |
| Interaction | PRRC2A interactions | 2.87e-05 | 389 | 82 | 9 | int:PRRC2A | |
| Interaction | CREBBP interactions | BMI1 BNIP3L CEBPA SPI1 GATA3 SMARCA2 SMARCC2 TBXT PAX7 EP300 CNOT3 | 3.02e-05 | 599 | 82 | 11 | int:CREBBP |
| Interaction | SP7 interactions | 3.31e-05 | 304 | 82 | 8 | int:SP7 | |
| Interaction | CHD7 interactions | 3.38e-05 | 150 | 82 | 6 | int:CHD7 | |
| Interaction | ERG interactions | 3.48e-05 | 223 | 82 | 7 | int:ERG | |
| Interaction | ZNF703 interactions | 3.87e-05 | 93 | 82 | 5 | int:ZNF703 | |
| Interaction | ZNF608 interactions | 3.87e-05 | 93 | 82 | 5 | int:ZNF608 | |
| Interaction | NFIX interactions | 3.89e-05 | 227 | 82 | 7 | int:NFIX | |
| Interaction | GSE1 interactions | 3.92e-05 | 154 | 82 | 6 | int:GSE1 | |
| Interaction | EP300 interactions | BMI1 CEBPA SPI1 TENT4A TLX3 GATA3 SMARCA2 AUTS2 SMARCC2 TBXT SEC31A RERE PAX7 WRAP53 IFI16 EP300 CNOT3 | 4.02e-05 | 1401 | 82 | 17 | int:EP300 |
| Interaction | SATB2 interactions | 4.69e-05 | 159 | 82 | 6 | int:SATB2 | |
| Interaction | GGTLC2 interactions | 4.89e-05 | 3 | 82 | 2 | int:GGTLC2 | |
| Interaction | ZYX interactions | 5.78e-05 | 329 | 82 | 8 | int:ZYX | |
| Interaction | DBP interactions | 6.00e-05 | 19 | 82 | 3 | int:DBP | |
| Interaction | KMT2D interactions | 6.58e-05 | 169 | 82 | 6 | int:KMT2D | |
| Interaction | SCYL1 interactions | 6.58e-05 | 169 | 82 | 6 | int:SCYL1 | |
| Interaction | UBAP2 interactions | 6.80e-05 | 170 | 82 | 6 | int:UBAP2 | |
| Interaction | RBPMS interactions | 7.28e-05 | 340 | 82 | 8 | int:RBPMS | |
| Interaction | CIITA interactions | 7.41e-05 | 55 | 82 | 4 | int:CIITA | |
| Interaction | MIDEAS interactions | 7.92e-05 | 108 | 82 | 5 | int:MIDEAS | |
| Interaction | FOXP1 interactions | 8.31e-05 | 256 | 82 | 7 | int:FOXP1 | |
| Interaction | HELZ interactions | 8.51e-05 | 257 | 82 | 7 | int:HELZ | |
| Interaction | ALG13 interactions | 1.02e-04 | 183 | 82 | 6 | int:ALG13 | |
| Interaction | KDM1A interactions | BMI1 CEBPA KIAA1217 GATA3 SMARCA2 TNRC6B SMARCC2 TBXT RERE ZMIZ1 ESCO1 EP300 CNOT3 | 1.03e-04 | 941 | 82 | 13 | int:KDM1A |
| Interaction | FBRSL1 interactions | 1.11e-04 | 61 | 82 | 4 | int:FBRSL1 | |
| Interaction | FLI1 interactions | 1.19e-04 | 62 | 82 | 4 | int:FLI1 | |
| Interaction | SMAP2 interactions | 1.22e-04 | 189 | 82 | 6 | int:SMAP2 | |
| Interaction | TBX21 interactions | 1.24e-04 | 24 | 82 | 3 | int:TBX21 | |
| Interaction | HNF1B interactions | 1.25e-04 | 190 | 82 | 6 | int:HNF1B | |
| Interaction | DDIT3 interactions | 1.30e-04 | 120 | 82 | 5 | int:DDIT3 | |
| Interaction | KHDRBS1 interactions | 1.38e-04 | 373 | 82 | 8 | int:KHDRBS1 | |
| Interaction | TLE6 interactions | 1.40e-04 | 25 | 82 | 3 | int:TLE6 | |
| Interaction | ARID3A interactions | 1.41e-04 | 122 | 82 | 5 | int:ARID3A | |
| Interaction | PAX7 interactions | 1.52e-04 | 124 | 82 | 5 | int:PAX7 | |
| Interaction | BICRA interactions | 1.61e-04 | 67 | 82 | 4 | int:BICRA | |
| Interaction | SPI1 interactions | 1.61e-04 | 67 | 82 | 4 | int:SPI1 | |
| Interaction | TCF7L2 interactions | 1.62e-04 | 285 | 82 | 7 | int:TCF7L2 | |
| Interaction | PUM1 interactions | 1.69e-04 | 287 | 82 | 7 | int:PUM1 | |
| Interaction | SMARCE1 interactions | 1.69e-04 | 287 | 82 | 7 | int:SMARCE1 | |
| Interaction | PITX1 interactions | 1.70e-04 | 127 | 82 | 5 | int:PITX1 | |
| Interaction | GCM1 interactions | 1.70e-04 | 68 | 82 | 4 | int:GCM1 | |
| Interaction | RING1 interactions | 1.70e-04 | 201 | 82 | 6 | int:RING1 | |
| Interaction | ACTL6A interactions | 1.76e-04 | 289 | 82 | 7 | int:ACTL6A | |
| Interaction | KLHDC7B interactions | 1.98e-04 | 28 | 82 | 3 | int:KLHDC7B | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.13e-05 | 25 | 49 | 3 | 775 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 7.39e-04 | 15 | 49 | 2 | 82 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 1.98e-03 | 92 | 49 | 3 | 521 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | FKBP15 SPHK2 ZNF142 SPI1 BICRA SMARCC2 RIPOR1 STING1 ZMIZ1 SIK3 ATXN1L EP300 AXIN1 | 5.15e-06 | 905 | 83 | 13 | M40865 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 8.03e-06 | 86 | 83 | 5 | M39248 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | CBLL1 BMI1 BNC2 CTTNBP2 KIF26B ROR2 AUTS2 PAX7 IFI16 PCDH8 SPTY2D1 | 2.29e-06 | 492 | 80 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.63e-05 | 214 | 80 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 2.23e-05 | 407 | 80 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.68e-05 | 243 | 80 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500 | 1.20e-04 | 67 | 80 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 1.69e-04 | 137 | 80 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 1.72e-04 | 416 | 80 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | BNC2 ZNF142 ATXN2 RBMS3 KIAA1217 SMARCA2 ZMIZ1 FAM171B SSBP3 ESCO1 CNOT3 | 1.78e-04 | 790 | 80 | 11 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | ZCCHC14 BNC2 ZNF142 ATXN2 RBMS3 KIAA1217 SMARCA2 ZMIZ1 SSBP3 ESCO1 CNOT3 | 2.00e-04 | 801 | 80 | 11 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CTTNBP2 KIF26B ROR2 GATA3 TBXT ZMIZ1 FAM171B CAMTA1 IFI16 FOXF1 PDLIM4 | 2.12e-04 | 806 | 80 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 2.83e-04 | 153 | 80 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | CBLL1 BMI1 BNC2 CTTNBP2 KIF26B ROR2 AUTS2 PAX7 IFI16 PCDH8 SPTY2D1 | 2.89e-04 | 836 | 80 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | ZCCHC14 BNC2 KIF26B IRS1 STING1 ZMIZ1 FAM171B IFI16 PCDH8 SPTY2D1 FOXF1 | 2.92e-04 | 837 | 80 | 11 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 9.08e-07 | 172 | 84 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.15e-06 | 179 | 84 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-06 | 190 | 84 | 6 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.62e-06 | 190 | 84 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.67e-06 | 191 | 84 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.77e-06 | 193 | 84 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.83e-06 | 194 | 84 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 1.88e-06 | 195 | 84 | 6 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 1.88e-06 | 195 | 84 | 6 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.88e-06 | 195 | 84 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.00e-06 | 197 | 84 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 198 | 84 | 6 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-06 | 199 | 84 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.48e-05 | 164 | 84 | 5 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-05 | 175 | 84 | 5 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-mLTo|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-05 | 180 | 84 | 5 | d1c52aeceb3627e3c5fb6cc3af77e0400f9380ab | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 181 | 84 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 181 | 84 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 185 | 84 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 185 | 84 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.71e-05 | 186 | 84 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.71e-05 | 186 | 84 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 2.85e-05 | 188 | 84 | 5 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-05 | 188 | 84 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.85e-05 | 188 | 84 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.93e-05 | 189 | 84 | 5 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | Control-Lymphoid-NK|World / Disease state, Lineage and Cell class | 2.93e-05 | 189 | 84 | 5 | 89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-05 | 189 | 84 | 5 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.00e-05 | 190 | 84 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 3.00e-05 | 190 | 84 | 5 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | Control-Lymphoid-NK|Control / Disease state, Lineage and Cell class | 3.00e-05 | 190 | 84 | 5 | f7bd8521a40ac30a64dc439f17e2f6c7d021ef65 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.08e-05 | 191 | 84 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.16e-05 | 192 | 84 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.23e-05 | 193 | 84 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.23e-05 | 193 | 84 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 3.23e-05 | 193 | 84 | 5 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.32e-05 | 194 | 84 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.32e-05 | 194 | 84 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 3.32e-05 | 194 | 84 | 5 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.32e-05 | 194 | 84 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.40e-05 | 195 | 84 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.40e-05 | 195 | 84 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 3.40e-05 | 195 | 84 | 5 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-05 | 195 | 84 | 5 | d70b49f6b9c6c4422adb2936c837a1af7569fb0a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.40e-05 | 195 | 84 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.40e-05 | 195 | 84 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.57e-05 | 197 | 84 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-05 | 199 | 84 | 5 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.83e-05 | 200 | 84 | 5 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 1.63e-04 | 145 | 84 | 4 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 1.63e-04 | 145 | 84 | 4 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-04 | 152 | 84 | 4 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-Microglia_Siglech|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-04 | 160 | 84 | 4 | c3f2f362e5d0602bb997e8367b4c9a8fe88e4ea8 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | 4e0133a7f80cf6bd3d70f72ee26360df5f80ab32 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | 4ab1a7d5379a633c3f61af1c8c2df93b6961d9cf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 166 | 84 | 4 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 166 | 84 | 4 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | COPD-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 2.74e-04 | 166 | 84 | 4 | e2cad1db536d5ad5a34c337c19b5e7d1a2851552 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-04 | 166 | 84 | 4 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.80e-04 | 167 | 84 | 4 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|World / disease group, cell group and cell class (v2) | 2.80e-04 | 167 | 84 | 4 | f26ae4de4804a3486502e3df37eabf3dfca688f5 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.87e-04 | 168 | 84 | 4 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 2.87e-04 | 168 | 84 | 4 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-04 | 169 | 84 | 4 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.00e-04 | 170 | 84 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 173 | 84 | 4 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 173 | 84 | 4 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.35e-04 | 175 | 84 | 4 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | COPD-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 3.35e-04 | 175 | 84 | 4 | e773e330de36f8a0aa9398a176ed7edb5599c582 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-04 | 176 | 84 | 4 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-04 | 176 | 84 | 4 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | COPD-Lymphoid-ILC_A|COPD / Disease state, Lineage and Cell class | 3.42e-04 | 176 | 84 | 4 | 484452cb38fe4604f0910a068361ed461b5b0c21 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-04 | 176 | 84 | 4 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.50e-04 | 177 | 84 | 4 | 15ee303fb6caea1fd645c3b777666196ce500a1c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.50e-04 | 177 | 84 | 4 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.50e-04 | 177 | 84 | 4 | d5503605d46a335cc7ca1f94626809f9e1b505e2 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 178 | 84 | 4 | cb9a446c145b1435cfe12a1d4568aed0924a6a20 | |
| ToppCell | Posterior_cortex-Hematopoietic|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.57e-04 | 178 | 84 | 4 | ea9e4f461dda34c0ebc707d7dbefc7a49ce5bb55 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.57e-04 | 178 | 84 | 4 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-04 | 178 | 84 | 4 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.57e-04 | 178 | 84 | 4 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-04 | 179 | 84 | 4 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.65e-04 | 179 | 84 | 4 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-04 | 179 | 84 | 4 | adf8b025032a03dbb58871a92025cd7efbeb22ff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-04 | 179 | 84 | 4 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.65e-04 | 179 | 84 | 4 | 5122fc794509492afde4af8b1b76d51e3070ef05 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-04 | 179 | 84 | 4 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.65e-04 | 179 | 84 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 1.35e-06 | 69 | 81 | 5 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | cortical thickness | BNC2 CTTNBP2 ATXN2 TLX3 AUTS2 TNRC6B TMEM108 RERE PAX7 CAMTA1 SSBP3 WNK2 SMAD5-AS1 | 1.01e-05 | 1113 | 81 | 13 | EFO_0004840 |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.39e-05 | 53 | 81 | 4 | C1961099 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.41e-05 | 286 | 81 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | cortical surface area measurement | BNC2 CTTNBP2 ATXN2 KIF26B TLX3 AUTS2 TNRC6B RERE PAX7 SSBP3 PICALM WNK2 AXIN1 SMAD5-AS1 | 1.63e-05 | 1345 | 81 | 14 | EFO_0010736 |
| Disease | neutrophil percentage of leukocytes | 4.52e-05 | 610 | 81 | 9 | EFO_0007990 | |
| Disease | body fat percentage | 5.91e-05 | 488 | 81 | 8 | EFO_0007800 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 6.52e-05 | 364 | 81 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | body surface area | 6.77e-05 | 643 | 81 | 9 | EFO_0022196 | |
| Disease | wellbeing measurement | 1.18e-04 | 692 | 81 | 9 | EFO_0007869 | |
| Disease | diet measurement | BNC2 CTTNBP2 KIF26B KIAA1217 SMARCA2 AUTS2 TNRC6B TMEM108 RERE CAMTA1 MAML3 | 1.36e-04 | 1049 | 81 | 11 | EFO_0008111 |
| Disease | mast/stem cell growth factor receptor kit measurement | 1.55e-04 | 7 | 81 | 2 | EFO_0020554 | |
| Disease | comparative body size at age 10, self-reported | 1.58e-04 | 420 | 81 | 7 | EFO_0009819 | |
| Disease | neuroimaging measurement | CTTNBP2 ATXN2 KIF26B ROR2 SMARCA2 TNRC6B RERE PAX7 CAMTA1 SSBP3 WNK2 | 1.60e-04 | 1069 | 81 | 11 | EFO_0004346 |
| Disease | corpus callosum volume measurement | 1.69e-04 | 100 | 81 | 4 | EFO_0010299 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.04e-04 | 195 | 81 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.34e-04 | 315 | 81 | 6 | EFO_0004612, EFO_0008591 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.65e-04 | 9 | 81 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | smoking cessation | 2.77e-04 | 325 | 81 | 6 | EFO_0004319 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 3.77e-04 | 51 | 81 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | corpus callosum posterior volume measurement | 4.00e-04 | 52 | 81 | 3 | EFO_0010298 | |
| Disease | choline measurement | 4.60e-04 | 130 | 81 | 4 | EFO_0010116 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 4.83e-04 | 12 | 81 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Secondary Open Angle Glaucoma | 4.83e-04 | 12 | 81 | 2 | C0271148 | |
| Disease | Glaucoma, Open-Angle | 4.83e-04 | 12 | 81 | 2 | C0017612 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 4.83e-04 | 12 | 81 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | lymphocyte percentage of leukocytes | 4.83e-04 | 665 | 81 | 8 | EFO_0007993 | |
| Disease | allergic rhinitis | 5.02e-04 | 133 | 81 | 4 | EFO_0005854 | |
| Disease | apolipoprotein A 1 measurement | 5.27e-04 | 848 | 81 | 9 | EFO_0004614 | |
| Disease | Coffin-Siris syndrome | 5.69e-04 | 13 | 81 | 2 | C0265338 | |
| Disease | Glaucoma, Primary Open Angle | 5.69e-04 | 13 | 81 | 2 | C0339573 | |
| Disease | reticulocyte measurement | FNDC3B BNC2 SPHK2 BNIP3L CEBPA ATXN2 TNRC6B IRS1 ATXN1L PICALM | 6.07e-04 | 1053 | 81 | 10 | EFO_0010700 |
| Disease | lymphocyte count | CBLL1 SPHK2 CEBPA CSF1 ATXN2 GATA3 AUTS2 TNRC6B RIPOR1 RERE ZMIZ1 PDLIM4 | 6.29e-04 | 1464 | 81 | 12 | EFO_0004587 |
| Disease | body weight | TENT4A RBMS3 KIAA1217 ROR2 AUTS2 TNRC6B IRS1 POC5 SSBP3 MAML3 AXIN1 | 6.49e-04 | 1261 | 81 | 11 | EFO_0004338 |
| Disease | granulocyte count | 6.83e-04 | 254 | 81 | 5 | EFO_0007987 | |
| Disease | respiratory system disease | 6.94e-04 | 145 | 81 | 4 | EFO_0000684 | |
| Disease | glaucoma | 8.69e-04 | 154 | 81 | 4 | MONDO_0005041 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 9.85e-04 | 17 | 81 | 2 | EFO_0008270 | |
| Disease | Acute myeloid leukemia | 9.85e-04 | 17 | 81 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 9.85e-04 | 17 | 81 | 2 | 601626 | |
| Disease | sphingomyelin measurement | 1.02e-03 | 278 | 81 | 5 | EFO_0010118 | |
| Disease | p-tau measurement | 1.04e-03 | 72 | 81 | 3 | EFO_0004763 | |
| Disease | thyroid peroxidase antibody measurement | 1.04e-03 | 72 | 81 | 3 | EFO_0005666 | |
| Disease | obsolete aging | 1.04e-03 | 279 | 81 | 5 | GO_0007568 | |
| Disease | obsolete_red blood cell distribution width | FNDC3B SPHK2 BNIP3L TENT4A KIAA1217 SMARCA2 SIK3 PICALM EP300 AXIN1 PDLIM4 | 1.11e-03 | 1347 | 81 | 11 | EFO_0005192 |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.12e-03 | 74 | 81 | 3 | DOID:3748 (is_marker_for) | |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 1.23e-03 | 19 | 81 | 2 | EFO_0002609, GO_0031427 | |
| Disease | glomerulonephritis (is_marker_for) | 1.23e-03 | 19 | 81 | 2 | DOID:2921 (is_marker_for) | |
| Disease | age at menarche | 1.24e-03 | 594 | 81 | 7 | EFO_0004703 | |
| Disease | smoking status measurement | ZCCHC14 BNC2 CTTNBP2 CSF1 ATXN2 BICRA AUTS2 RERE CAMTA1 MAML3 | 1.27e-03 | 1160 | 81 | 10 | EFO_0006527 |
| Disease | Leukemia, Myelocytic, Acute | 1.34e-03 | 173 | 81 | 4 | C0023467 | |
| Disease | neutrophil count | BNC2 SPHK2 BNIP3L SPI1 ATXN2 POC5 RERE ZMIZ1 SIK3 IFI16 WIPF2 | 1.36e-03 | 1382 | 81 | 11 | EFO_0004833 |
| Disease | citrulline measurement | 1.37e-03 | 20 | 81 | 2 | EFO_0009777 | |
| Disease | response to selective serotonin reuptake inhibitor | 1.51e-03 | 82 | 81 | 3 | EFO_0005658 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 1.51e-03 | 21 | 81 | 2 | C1292769 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.62e-03 | 84 | 81 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.70e-03 | 312 | 81 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 1.77e-03 | 315 | 81 | 5 | EFO_0004574, EFO_0004612 | |
| Disease | open-angle glaucoma | 1.92e-03 | 191 | 81 | 4 | EFO_0004190 | |
| Disease | periodontal measurement | 1.98e-03 | 24 | 81 | 2 | EFO_0007780 | |
| Disease | triacylglycerol 56:4 measurement | 1.98e-03 | 24 | 81 | 2 | EFO_0010431 | |
| Disease | visceral adipose tissue measurement | 2.11e-03 | 481 | 81 | 6 | EFO_0004765 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.17e-03 | 330 | 81 | 5 | EFO_0004529, EFO_0004612 | |
| Disease | reticulocyte count | 2.25e-03 | 1045 | 81 | 9 | EFO_0007986 | |
| Disease | glycerol measurement | 2.32e-03 | 26 | 81 | 2 | EFO_0010115 | |
| Disease | unipolar depression, depressive symptom measurement | 2.32e-03 | 26 | 81 | 2 | EFO_0003761, EFO_0007006 | |
| Disease | Inhalant adrenergic use measurement | 2.37e-03 | 96 | 81 | 3 | EFO_0009941 | |
| Disease | Adenocarcinoma of large intestine | 2.37e-03 | 96 | 81 | 3 | C1319315 | |
| Disease | PR interval | 2.43e-03 | 495 | 81 | 6 | EFO_0004462 | |
| Disease | S-warfarin measurement | 2.44e-03 | 97 | 81 | 3 | EFO_0803323 | |
| Disease | smoking behavior | 2.50e-03 | 341 | 81 | 5 | EFO_0004318 | |
| Disease | lobe attachment | 2.57e-03 | 207 | 81 | 4 | EFO_0007667 | |
| Disease | Adenoid Cystic Carcinoma | 2.66e-03 | 100 | 81 | 3 | C0010606 | |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 2.69e-03 | 28 | 81 | 2 | EFO_0004647, EFO_0005208 | |
| Disease | triacylglycerol 54:7 measurement | 2.69e-03 | 28 | 81 | 2 | EFO_0010425 | |
| Disease | immune system disease | 2.69e-03 | 28 | 81 | 2 | EFO_0000540 | |
| Disease | Vitiligo | 2.74e-03 | 101 | 81 | 3 | EFO_0004208 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.74e-03 | 101 | 81 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPSPRMQPQPSPHHV | 2326 | Q09472 | |
| MQPQPSPHHVSPQTS | 2331 | Q09472 | |
| TMSPTAGPNHHLLSP | 411 | Q9Y6Y1 | |
| MAHLGPTPPPHSLNY | 1 | Q6ZN30 | |
| HQDNTHPSAPMPPPS | 126 | P51816 | |
| TSGMPVPALFPHPQH | 86 | Q3C1V8 | |
| PPYHHQMPPPHSDTV | 646 | O75175 | |
| KHPMVNDTPSSPSPA | 271 | Q6P387 | |
| APHPMAPPSPSTNSS | 31 | Q6XE24 | |
| MHPGTDQHSPIPLST | 886 | Q9H0J4 | |
| STVHRPQPLPPSTMH | 321 | P23759 | |
| APPPPVLMHHGESSQ | 206 | P04217 | |
| EHSAHLDPSAPPMPL | 396 | Q8NA72 | |
| SSAAHEHPPMLVNPP | 356 | Q9P2G4 | |
| HSPQSPPEGMHSQSP | 661 | O60732 | |
| PSHSPFAHVSMGSPQ | 361 | Q96JK9 | |
| HSMTNLPAYPVPQHP | 216 | Q86UW9 | |
| TPPPITSSHLPSHFM | 456 | P0C7T5 | |
| VQSGMVPSHPTAHAP | 1251 | Q99700 | |
| MQRSHSPVPAAAPAH | 1001 | Q2KJY2 | |
| SPHPQFPHISSTMNG | 281 | P35226 | |
| GPNAHPSPHPPAQMS | 971 | O95206 | |
| SLHPAHPALPQMTSQ | 411 | Q5T1M5 | |
| PTLQPPAHSHHPNMF | 446 | Q8WXX7 | |
| PAHSHHPNMFAPPTA | 451 | Q8WXX7 | |
| HSSHPSPAPVLPVNA | 851 | Q8WXX7 | |
| PPAATGHSMVFHAPS | 386 | Q7Z7M0 | |
| PPSHADHTPMPQAII | 121 | Q14390 | |
| HPPLNHSRSIPMPAS | 366 | P35568 | |
| HMSSPAIPSASPNPL | 686 | Q5XG87 | |
| ISHPMPHPPQAAGTP | 351 | Q75N03 | |
| HSSHMLTTPTPMHPP | 411 | P23771 | |
| DPASVSPHQPLAPSM | 201 | P09603 | |
| SMPSPPLANSNHESP | 21 | F2Z3M2 | |
| MHPEPLLNSTQSAPH | 1 | A8K830 | |
| APQNSQAPPMHSLHS | 416 | Q8WZ74 | |
| QAPPMHSLHSPCANT | 421 | Q8WZ74 | |
| PRPPMSSHLQSPPHA | 11 | P49715 | |
| TTMHLQPGHPTPPPT | 216 | P49715 | |
| PSYPSAMSPTHHLPP | 111 | Q53EP0 | |
| SHLFIQDPTMPPHPA | 686 | O15169 | |
| HPSPLMPHENPASGK | 341 | P51810 | |
| MSSHLVEPPPPLHNN | 1 | O60238 | |
| FSDPPQPNHSIHTGM | 476 | Q7Z591 | |
| PAPAPCHANTSMVTH | 56 | Q9Y2A9 | |
| GPAESHPHTPQMPPS | 476 | Q16666 | |
| IGPAESHPHTPQMPP | 531 | Q16666 | |
| SFSPPALEMHHPVTQ | 421 | Q5FWF5 | |
| TAPSHAPAPAPMAAT | 1011 | Q9NZM4 | |
| SSPPSHFCPHPMSLS | 611 | P37088 | |
| LPKMPIHSHAQPPDA | 586 | Q6P995 | |
| GHSQPMGSPASPQPH | 1741 | Q6ZRI0 | |
| AAMTQAHPPTHIAPP | 1866 | Q6ZRI0 | |
| MALPSHSVPHLPSNG | 206 | Q12946 | |
| MPHSSLHPSIPCPRG | 1 | Q86WV6 | |
| PPHNPSSMMGPHSQP | 136 | Q9BWW4 | |
| APAHPSPHASPMNKN | 21 | Q9BUR4 | |
| MSPHPSPLGAPEHVS | 121 | P51531 | |
| HPVQSQPGLSAHMAP | 56 | Q6ZSG1 | |
| PAQMSTLHVSPPPSA | 156 | P50479 | |
| HSTLPPRAHPAPSMG | 1526 | Q9P2F8 | |
| NAHGPPHTMQPDRAS | 491 | Q5T5P2 | |
| SPTPPHGYAHQPALM | 1076 | Q9Y2K2 | |
| ASSQLSQAPPQPHHM | 486 | Q6ZUB1 | |
| HSHSSSLCFPMPPFP | 236 | P0C7M4 | |
| KHPPHLSGPSPFSMN | 946 | Q9P2R6 | |
| VPPQMVPKPSSHHSG | 851 | Q01974 | |
| LDTPMVPPHPSLGHQ | 96 | P17947 | |
| SHPSHSRPGPMVTPH | 346 | Q68D10 | |
| TPMGPPPTSHFHVLA | 521 | Q8TAQ2 | |
| LQQPTFHPSVHPMST | 396 | Q13492 | |
| SLVSPHGPHMPPAAS | 516 | Q8ND24 | |
| DPAPPMAHSPLHRSV | 406 | Q9NRA0 | |
| PPSLNTMSDPHAHFN | 381 | Q86U17 | |
| APHPPSRMHNSPTQN | 361 | Q76KD6 | |
| PHHASNPNSPLSNPM | 416 | A7XYQ1 | |
| PTSSPMHRPMLSPHI | 446 | A7XYQ1 | |
| MHRPMLSPHIHPPST | 451 | A7XYQ1 | |
| CQSHPQSMPHRKPVP | 1511 | Q6ZQQ2 | |
| PAHPSMLPVSHNASP | 326 | O15178 | |
| HSHSSSLCFPMPPFP | 236 | Q9BQY4 | |
| MEAPASAQTPHPHEP | 1 | O43711 | |
| SCASLPHMHKNPPPS | 351 | Q0D2K0 | |
| MLPHNTTEAPGPHSA | 16 | Q53FD0 | |
| NPSGHHPLPPQMLSA | 486 | Q8WYQ9 | |
| MASQHHPGTPAPLYP | 531 | P52746 | |
| ANAPPTPLPMHSSKA | 186 | Q8TF74 | |
| FPQMAPTDVPPSPHH | 916 | Q9Y3S1 | |
| PTDVPPSPHHTVQNM | 921 | Q9Y3S1 | |
| PSPHHTVQNMRATPP | 926 | Q9Y3S1 | |
| SHSSPTGLPKPHSPM | 41 | Q9Y6J3 | |
| QLPTSPGHMHTQVPP | 856 | O94979 | |
| ADPMAPRTPHPSPAH | 721 | Q6ZS17 | |
| VHSAPSTMPKHSPSP | 341 | Q9NWH7 | |
| MPHAGSSDQPHPSIQ | 946 | Q9ULJ6 | |
| SPSHPVGPKPHLDNM | 1336 | Q9UPQ9 | |
| MATPTPRAEGHPPTH | 81 | Q6UXF1 |